Illumina pushes back against Carl Icahn’s proxy fight over Grail deal
Carl IcahnAdam Jeffery | CNBC Biotech company Illumina pushed back Monday against Carl Icahn's proxy fight over the corporate's acquisition ...
Carl IcahnAdam Jeffery | CNBC Biotech company Illumina pushed back Monday against Carl Icahn's proxy fight over the corporate's acquisition ...